In 2013, Congress passed the Drug Quality and Security Act (DQSA), which tightened federal control over compounding pharmacies.
To implement the law, the FDA is setting guidelines for what can be compounded at “traditional” pharmacies (503A facilities) and outsourcing pharmacies (503B facilities).